Inspection Record

Atlas Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-12-17 4 findingsEquipment and facilityLaboratory and QC controlsDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.

2Laboratory and QC controls

The validation and/or the documentation of test methods was inadequate.

3Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-12-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Atlas Pharma Inc. company profile — full history Health Canada documents, 2024 Go to Findings search